Literature DB >> 8624620

Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue.

A Balsa1, J Dixey, D M Sansom, P J Maddison, N D Hall.   

Abstract

CD4+ T-lymphocytes require two signals to become activated--antigen receptor (TcR) occupancy and an antigen-presenting cell (APC)-derived costimulus. The latter may be provided by B7.1 (CD80) or B7.2 (CD86) on APC interacting with CD28 on T-cells. We have studied the expression of these costimulatory molecules in rheumatoid and osteoarthritic synovial membrane. Very few B7.1-positive cells were seen in synovial tissue from either established or early rheumatoid disease, or in rheumatoid arthritis (RA) or osteoarthritis (OA) synovia at arthroplasty. In contrast, B7.2 was readily detected in rheumatoid synovia, predominantly in the lining layer, in a pattern of expression that corresponded to the presence of CD68-positive macrophages. Only occasional B7.2-positive cells were seen in OA synovia. The presence of B7.2 but the relative lack of expression of B7.1 may be partly responsible for the observations of 'frustrated' T-cell activation or T-cell hyporesponsiveness in the rheumatoid synovium.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624620     DOI: 10.1093/rheumatology/35.1.33

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  10 in total

Review 1.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Glandular and extraglandular expression of costimulatory molecules in patients with Sjögren's syndrome.

Authors:  R Matsumura; K Umemiya; T Goto; T Nakazawa; M Kagami; H Tomioka; E Tanabe; T Sugiyama; M Sueishi
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

3.  Quantitation of IL-2Rp75 (CD122) expression on mononuclear cells in rheumatic disease.

Authors:  P Creamer; N D Hall
Journal:  Ann Rheum Dis       Date:  1996-11       Impact factor: 19.103

4.  Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes.

Authors:  N Lambert; P L Lescoulié; B Yassine-Diab; G Enault; B Mazières; C De Préval; A Cantagrel
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

5.  Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis.

Authors:  Dragana Odobasic; Michelle T Leech; Jin R Xue; Stephen R Holdsworth
Journal:  Immunology       Date:  2008-01-24       Impact factor: 7.397

6.  Intimal lining layer macrophages but not synovial sublining macrophages display an IL-10 polarized-like phenotype in chronic synovitis.

Authors:  Carmen A Ambarus; Troy Noordenbos; Maria J H de Hair; Paul P Tak; Dominique L P Baeten
Journal:  Arthritis Res Ther       Date:  2012-04-11       Impact factor: 5.156

Review 7.  Current perspectives on synovitis.

Authors:  P P Tak; F C Breedveld
Journal:  Arthritis Res       Date:  1999-10-26

8.  Resistance to IL-10 inhibition of interferon gamma production and expression of suppressor of cytokine signaling 1 in CD4+ T cells from patients with rheumatoid arthritis.

Authors:  Jiro Yamana; Masahiro Yamamura; Akira Okamoto; Tetsushi Aita; Mitsuhiro Iwahashi; Katsue Sunahori; Hirofumi Makino
Journal:  Arthritis Res Ther       Date:  2004-10-13       Impact factor: 5.156

9.  Polarization of Rheumatoid Macrophages by TNF Targeting Through an IL-10/STAT3 Mechanism.

Authors:  Yannick Degboé; Benjamin Rauwel; Michel Baron; Jean-Frédéric Boyer; Adeline Ruyssen-Witrand; Arnaud Constantin; Jean-Luc Davignon
Journal:  Front Immunol       Date:  2019-01-18       Impact factor: 7.561

10.  CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production.

Authors:  Maurizio Cutolo; Stefano Soldano; Paola Montagna; Alberto Sulli; Bruno Seriolo; Barbara Villaggio; Pierfranco Triolo; Paolo Clerico; Lamberto Felli; Renata Brizzolara
Journal:  Arthritis Res Ther       Date:  2009-11-23       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.